Institutional net value surged $69.1B with 2,688 buyers versus 2,944 sellers, yet insiders sold $80.5M across 17 transactions with zero buys in the last 90 days.

Confirmation

Continued divergence without a clear shift—either a spike in insider buying or a reversal in institutional flows—would confirm the standoff.

Invalidation Risk

A breakout in either direction, such as a cluster of insider buying or a major institutional exit, would invalidate the neutral call.

AI-generated from public SEC disclosures and limited to historical data. Should not be relied upon as the sole basis for any investment decision.

Insider Trading (Form 4)

90d confidence

unique buyers

—

buy value

data as of 2026-07-17

12-Month Buy/Sell Activity

Feb 25

Sep 25

Jan 26

BuySell

Action	Insider	Title	Date	Value
Sell	Decker Robert J	VP Corporate Controller	2026-02-27	$1.01M
Sell	Schmid Timothy	EVP, WW Chair, MedTech	2026-02-20	$325K
Sell	Schmid Timothy	EVP, WW Chair, MedTech	2026-02-18	$2.20M
Sell	Schmid Timothy	EVP, WW Chair, MedTech	2026-02-18	$3.33M
Sell	Swanson James D.	EVP, CIO	2026-02-17	$4.98M
Sell	Wolk Joseph J	Exec VP, CFO	2026-02-17	$4.68M
Sell	Wolk Joseph J	Exec VP, CFO	2026-02-17	$6.06M
Sell	Wolk Joseph J	Exec VP, CFO	2026-02-17	$8.10M

View all insider trades →

Form 144 Pre-Sale Notices

Filings (90d)

$2.40M

Total Est. Value

10K shares

Planned Shares

Last Filed 2026-06-11

Filer	Title/Relationship	Filing Date	Planned Shares	Est. Value
Wengel Kathryn E	Officer	2026-06-11	10K shares	$2.40M

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

Filings (14d)

Data as of 2026-07-15

2026-07-15

Johnson & Johnson announced its second quarter 2026 financial results on July 15, 2026, for the quarter ended June 28, 2026. The results were disclosed in a press release attached to this 8-K filing.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding JOHNSON & JOHNSON (JNJ)?

Major stakeholders currently include BlackRock, Inc. ($58.9B), Vanguard Capital Management LLC ($43.5B), State Street CORP ($36.3B). Based on the latest 13F filings, there are a total of 6181 tracked investment funds and institutions maintaining positions in JNJ.

What is the overall institutional sentiment toward JNJ recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $69.1B, driven by 2689 managers accumulating shares while 2944 reduced their exposure.

Which institutions have been selling or reducing their JNJ positions?

In the latest period, 2734 funds trimmed their holdings, and 210 managers completely exited their positions. The aggregate reported sell value was $198.9B.

Are there any notable investors adding JNJ to their portfolios?

Yes, buying activity remains notable. 416 institutions opened new positions in {ticker}, and 2273 existing holders added to their shares. The total reported buy value for the quarter amounted to $241.1B.